Andrew Shepherd

Andrew Shepherd has a diverse work experience spanning multiple companies and roles. Andrew currently serves as the VP Clinical Partnerships at BioRestorative Therapies, Inc. since February 2022. Prior to that, they were the VP of New Product Development at Nano18 since January 2021. In 2014, Andrew became the Owner of Orion Orthobiologic. Andrew also worked as the Distributor Manager at VisionScope Technologies from September 2013 to August 2014. Before that, Andrew held the position of Ortho at Smith & Nephew from April 2007 to September 2013. Andrew started their professional career at sanofi-aventis, where they worked as a Secondary Care representative from September 2001 to January 2007 and as a Rep from March 2001 to January 2003.

Andrew Shepherd completed a Certificate in Business Management from New York University from 2011 to 2013. Prior to that, from 1995 to 1998, they obtained a Bachelor of Science (BSc) (HONS) degree in Sport & Exercise Physiology from the University of Portsmouth.